| Nome |
# |
|
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation, file e14fb26b-7eb9-3de1-e053-1705fe0ac030
|
293
|
|
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals., file e14fb269-ca2c-3de1-e053-1705fe0ac030
|
249
|
|
Is osteoporosis a peculiar association with primary biliary cirrhosis?, file e14fb267-7d8a-3de1-e053-1705fe0ac030
|
247
|
|
Educazione alla salute in giovani pazienti sottoposti a trapianto di fegato. Progetto pilota di strutturazione e implementazione di strumenti di dialogo educativo condotto presso l’Azienda Ospedaliera di Padova, file e14fb26a-0961-3de1-e053-1705fe0ac030
|
246
|
|
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents, file e14fb269-f428-3de1-e053-1705fe0ac030
|
225
|
|
Liver transplantation for viral hepatitis in 2015, file e14fb268-acc6-3de1-e053-1705fe0ac030
|
188
|
|
Markers of acute rejection and graft acceptance in liver transplantation., file e14fb269-ee7f-3de1-e053-1705fe0ac030
|
188
|
|
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study, file e14fb26b-7ead-3de1-e053-1705fe0ac030
|
150
|
|
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis., file e14fb269-cb8c-3de1-e053-1705fe0ac030
|
142
|
|
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors, file e14fb269-f275-3de1-e053-1705fe0ac030
|
140
|
|
Therapeutic approaches for portal biliopathy: A systematic review, file e14fb269-f03f-3de1-e053-1705fe0ac030
|
131
|
|
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study, file e14fb26b-2687-3de1-e053-1705fe0ac030
|
124
|
|
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma., file e14fb26b-284b-3de1-e053-1705fe0ac030
|
119
|
|
Timing for treatment of HCV recurrence after liver transplantation: the earlier the better., file e14fb268-31b3-3de1-e053-1705fe0ac030
|
117
|
|
Management of bacterial infection in the liver transplant candidate, file e14fb26a-b676-3de1-e053-1705fe0ac030
|
115
|
|
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?, file e14fb26b-7eaf-3de1-e053-1705fe0ac030
|
114
|
|
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites, file e14fb26b-2685-3de1-e053-1705fe0ac030
|
112
|
|
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension, file e14fb269-f042-3de1-e053-1705fe0ac030
|
108
|
|
New Perspectives in Liver Transplantation: From Regeneration to Bioengineering, file e14fb26b-d969-3de1-e053-1705fe0ac030
|
107
|
|
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma, file e14fb26a-6ec8-3de1-e053-1705fe0ac030
|
106
|
|
Invasive fungal infection before and after liver transplantation, file e14fb26e-8275-3de1-e053-1705fe0ac030
|
95
|
|
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy, file e14fb26b-8654-3de1-e053-1705fe0ac030
|
89
|
|
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation, file e14fb26e-e9bc-3de1-e053-1705fe0ac030
|
69
|
|
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients, file e14fb270-4309-3de1-e053-1705fe0ac030
|
67
|
|
Neoplastic disease after liver transplantation: Focus on de novo neoplasms, file e14fb269-eda3-3de1-e053-1705fe0ac030
|
60
|
|
The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): A post-hoc between-sex analysis, file e14fb26c-741b-3de1-e053-1705fe0ac030
|
60
|
|
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis, file e14fb267-8879-3de1-e053-1705fe0ac030
|
52
|
|
Management of hepatocellular carcinoma recurrence after liver transplantation, file e14fb26f-8e2b-3de1-e053-1705fe0ac030
|
48
|
|
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows, file e14fb26f-9c33-3de1-e053-1705fe0ac030
|
48
|
|
Umbilical cord mesenchymal stem cells modulate dextran sulphate sodium induced acute colitis in immunodeficient mice., file e14fb26e-f62c-3de1-e053-1705fe0ac030
|
47
|
|
Digestive cancer screening across Europe, file e14fb270-4eec-3de1-e053-1705fe0ac030
|
41
|
|
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC, file e14fb26f-8466-3de1-e053-1705fe0ac030
|
36
|
|
Hepatitis C virus infection in end stage renal disease and kidney transplantation, file e14fb26a-0571-3de1-e053-1705fe0ac030
|
29
|
|
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study, file e14fb26a-bb57-3de1-e053-1705fe0ac030
|
23
|
|
Effect of Portal Vein Thrombosis (pvt) On Survival After Liver Transplantation (lt): A Metanalysis, file 6f44398c-cb3b-4082-aa85-aaad55b46966
|
21
|
|
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma, file e14fb267-8acd-3de1-e053-1705fe0ac030
|
21
|
|
Hepatocellular carcinoma in chronic viral hepatitis: Where do we stand?, file e14fb270-51b8-3de1-e053-1705fe0ac030
|
18
|
|
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma, file e14fb267-8639-3de1-e053-1705fe0ac030
|
17
|
|
Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury., file e14fb267-9f0f-3de1-e053-1705fe0ac030
|
16
|
|
Bax Inhibitor-1 down-regulation in the progression of chronic liver diseases, file e14fb267-892f-3de1-e053-1705fe0ac030
|
14
|
|
Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients, file e14fb270-4b3a-3de1-e053-1705fe0ac030
|
14
|
|
Female gender in the setting of liver transplantation., file e14fb269-f045-3de1-e053-1705fe0ac030
|
13
|
|
Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or "Wait and See" Strategy?, file e14fb26e-c4c6-3de1-e053-1705fe0ac030
|
11
|
|
Liver transplantation for t2 hepatocellular carcinoma during the covid-19 pandemic: A novel model balancing individual benefit against healthcare resources, file e14fb26e-bf4d-3de1-e053-1705fe0ac030
|
10
|
|
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis, file 071fbe4f-c688-458c-b8b3-090d393d61c4
|
9
|
|
Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients, file 3c6e99af-8783-44c1-8b1a-101fb7d2e6e1
|
9
|
|
From the Editor's Desk…, file e14fb26e-da7f-3de1-e053-1705fe0ac030
|
9
|
|
From the Editor's Desk…, file e14fb26f-1d3e-3de1-e053-1705fe0ac030
|
9
|
|
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study, file d06eac0a-35fe-4bd1-a041-9be7146ffa1d
|
8
|
|
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies., file e14fb267-9d0d-3de1-e053-1705fe0ac030
|
8
|
|
Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement., file e14fb269-f272-3de1-e053-1705fe0ac030
|
8
|
|
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?, file e14fb26b-2952-3de1-e053-1705fe0ac030
|
8
|
|
From the Editor's Desk., file 477796d7-31c0-4391-9a6d-1846230b9778
|
7
|
|
From the Editor's Desk…, file e14fb26d-2151-3de1-e053-1705fe0ac030
|
7
|
|
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy, file e14fb270-1e8e-3de1-e053-1705fe0ac030
|
7
|
|
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria, file e14fb267-8f6a-3de1-e053-1705fe0ac030
|
6
|
|
Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation, file e14fb26b-2954-3de1-e053-1705fe0ac030
|
6
|
|
From the Editor's Desk…, file e14fb26e-dea1-3de1-e053-1705fe0ac030
|
6
|
|
From the Editor's Desk…, file e14fb26f-0c1e-3de1-e053-1705fe0ac030
|
6
|
|
Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients, file fa68632e-10e5-41ee-93a9-1a67e455d9bf
|
6
|
|
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection, file cd78d1e9-16cb-40e0-a741-2383b701f663
|
5
|
|
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential, file e14fb267-9061-3de1-e053-1705fe0ac030
|
5
|
|
Neuropsychological alterations in hepatitis C infection: the role of inflammation., file e14fb269-f043-3de1-e053-1705fe0ac030
|
5
|
|
New insights into the coagulopathy of liver disease and liver transplantation, file e14fb269-f8ca-3de1-e053-1705fe0ac030
|
5
|
|
Therapeutic application of stem cells in gastroenterology: an up-date, file e14fb26b-2178-3de1-e053-1705fe0ac030
|
5
|
|
From the Editor's Desk…, file e14fb26e-bf4c-3de1-e053-1705fe0ac030
|
5
|
|
Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon, file e14fb270-4b3d-3de1-e053-1705fe0ac030
|
5
|
|
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review., file 30d3eb32-789f-4aa5-84da-ac4c5064d212
|
4
|
|
Can the Multidimensional Prognostic Index (MPI) be a predictive instrument for mortality in older adult liver transplant candidates?, file 4c548ddb-ca62-437e-86cc-8096877eeb53
|
4
|
|
Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: A systematic review and critical appraisal, file 587f0b28-c0e3-4635-ab07-dec9b481b225
|
4
|
|
From the Editor's Desk…, file e14fb26f-21e9-3de1-e053-1705fe0ac030
|
4
|
|
Micronuclei and broken eggs in human liver carcinogenesis, file e14fb267-94af-3de1-e053-1705fe0ac030
|
2
|
|
Veno occlusive disease: up-date on clinical menagement., file e14fb269-f51e-3de1-e053-1705fe0ac030
|
2
|
|
From the Editor's Desk, file 54237c3a-76c0-43d7-97d1-816f993480a8
|
1
|
|
From the Editor's Desk, file 5e7bc583-9a07-4e60-985f-5855b6eab932
|
1
|
|
From the Editor's Desk, file c89b5bba-e64f-4cc8-b6ff-7c746ee59317
|
1
|
|
Understanding of and attitudes to organ donation and transplantation: a survey among Italian university students, file e14fb267-6148-3de1-e053-1705fe0ac030
|
1
|
|
The Impact of Hepatitis C and Biliary Complications on Patient and Graft Survival Following Liver Transplantation, file e14fb267-765c-3de1-e053-1705fe0ac030
|
1
|
|
Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury., file e14fb26a-7ef9-3de1-e053-1705fe0ac030
|
1
|
|
Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference, file e14fb26e-20db-3de1-e053-1705fe0ac030
|
1
|
| Totale |
4.321 |